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ABSTRACT:

Chronic kidney disease is a growing area of nutritional concern as the number of
diagnosed cases increases. Children suffering from these renal diseases require special
attention and medical nutrition therapy because of concerns and problems unique to this
renal population. Uncontrolled kidney failure in pediatric patients can result in a number
of consequences, such as growth retardation , anemia, metabolic imbalances, renal
osteodystrophy , anorexia , and malnutrition . With the proper guidance , medical
interventions , and dietary prescriptions , these untimely side effects can be reduced or
avoided all together.

Nutritional Concerns and Treatment in Pediatric Renal Disease

INTRODUCTION:
Rates of chronic renal disease in this nation are steadily increasing (1 ). In fact,
the National Kidney Foundation states that 20 million Americans, or one in nine people,
have chronic renal disease. The National Kidney Foundation also estimates that another
20 million Americans are largely at risk for chronic renal disease.
Chronic renal disease does not only affect adults; children and adolescents make
up nearly 2% of those diagnosed with chronic renal diseases. Although the pediatric
population makes up such a small percentage of those suffering, it is currently a major
nutritional concern because of the detrimental outcomes such as growth retardation and
metabolic bone disease can be lessened or avoided with proper nutritional intervention
(2).

BACKGROUND OF THE KIDNEYS:
The kidneys are an essential part of the human body and the complex organ
system within it. The main function of the kidneys is to control the homeostatic balance
in the body (3). This intricate balance is achieved by maintaining the proper ratio of
fluids, electrolytes such as sodium and potassium, and other particles inside the body .
This task of fluid-electrolyte maintenance is influenced by various factors such as the
volume of fluids in the body and the fluctuating concentration of sodium.
Achieving the proper homeostasis within the body is a major task. Thus, the
kidneys are a complicated and highly adaptable organ system (3). Kidneys can excrete

urine as concentrated as 1200 milliosmols (mOsm) or as dilute as 50 mOsm. Along with
regulating urine concentration, the kidneys maintain proper fluid balance in the body by
their ability to control the volume of fluid and urine excreted. According to MahanStump (3), "the kidneys can get rid of as little as 500 ml of concentrated urine or as much
as 12 L."
The average daily solute load, or "end products from normal metabolism" , is
typically 600 mOsm. In order to excrete these solutes, the body requires a bare minimum
of 500 ml of fluid collected by the kidneys. When the kidneys are unable to excrete that
minimum volume, the solutes are not excreted adequately and they begin to collect inside
the body. Urine excretion of less than 500 ml is medically tenned oliguria (3) .
Although fluid-electrolyte balance is the main duty of the kidneys , they are also
responsible for another function as well, which is blood pressure regulation . When blood
volume is low, the glomerulus of the kidney is stimulated to secrete a proteolytic enzyme
called renin. Mahan-Stump (3) explain that "renin acts on angiotensinogen in the plasma
to form angiotensin I, which is converted to angiotensin II, a powerful vasoconstrictor
and potent stimulus of aldosterone secretion by the adrenal gland." This complex
cascade ultimately result s in sodium reabsorption , causing a rise in blood pressure (3).
The kidneys play a role in red blood cell production by synthesizing
erythropoietin, a hormone that stimulates the formation of red blood cells in bone
marrow. Without this critical hormone, hypochromic anemia often results. In fact,
severe anemia is all too common in those suffering from chronic renal disease (3).
Another important function of the kidneys is in maintaining proper bone health
(3). The kidney is responsible for the conversion of the inactive form of vitamin D to the
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active form, 1,25-(0H)2D3, and in the regulation of the balance between calcium and
phosphorus. Active vitamin Dis especially important for good bone health because it
allows for calcium to be absorbed from the intestines after ingestion.
When kidneys are not functioning properly, there is a very distinct and
detrimental relationship between vitamin D , phosphorus, calcium, and parathyroid
hormone (PTH) (3). First, when kidney function begins to decline, there is a decrease in
the production of active vitamin D, leading to a decrease in the absorption of calcium
from the gut. Second, failing kidneys result in a decrease of the clearance of solutes and
other minerals. Thus, phosphorus will not be excreted properly and will be allowed to
build up in the body. This results in an increase in a calcium-phosphate product, leading
to the calcification of soft tissues. Also , since serum calcium is being bound by the
phosphate , there is a significant decrease in the levels of serum calcium . This particular
decrease in calcium signals PTH to begin drawing calcium from the bones to replenish
the serum calcium stores .
In adults, the most common causes of renal failure are diabetes mellitus,
hypertension, and glomerulonephritis (3, 4). While hypertension and diabetes can largely
be prevented or stabilized in adults, the most common causes of pediatric renal failure
cannot be controlled. These causes include congenital defects, hypodysplasia, chronic
glomerulonephritis, reflux nephropathy, and systemic immunity diseases (2,4). Often
times, renal congenital defects can only be repaired by a kidney transplant.
The progression of chronic renal disease usually encompasses renal insufficiency
(RI) followed by end stage renal disease (ESRD) (2,4 ). These two disease states are
characterized by their decreased glomerular filtration rate (GFR). The GFR is defined as
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the "rate at which the blood is filtered by the glomeruli in individual nephrons" of the
kidney, and is a direct measurement of the percentage of kidney function. A normal,
healthy GFR is between 90-100 ml/min/1.73m2.

Renal insufficiency is defined as a GFR

at or below 70 ml/min/1 .73m2, whereas ESRD , or chronic renal failure (CRF), entails a
GFR ofless than 5-10 ml/min/1.73m2 (4).
NUTRITIONAL CONCERNS IN CHRONIC RENAL DISEASE:
Uncontrolled renal insufficiency and failure in pediatric patients can cause severe,
negative effects. Medical and nutrition therapy for children aims to control side effects
such as stunted growth , renal osteodystrophy , fluid and electrolyte imbalances, the
accumulation of toxic wastes in the body, acidosis , anemia , hypertension , anorexia , and
malnutrition (2).
Growth retardation is one of the most severe and long-lasting side effects.
According to Cynthia J. Terrill (4), the four causes of growth restriction in pediatric renal
patients are malnutrition , osteodystrophy, acidosis, and resistance to growth hormones.
Other factors also affect growth rates over time, such as the age at the onset of renal
disease, the GFR , the nutritional adequacy of dietary intakes, and imbalances in
metabolism and honnones.
The child's age at the onset of disease can have a huge impact on growth .
Congenital renal diseases that are manifested at birth and early childhood have the
biggest impact on growth since this is the time in life where growth is rapid and proper
nutrition is crucial (2). Spinozzi (2) concludes that "acquired diseases such as chronic
glomerulonephritis have less impact on growth, due to their more insidious onset."
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The administration of growth hormone (rhGH) is a common, but sometimes
controversial, method of treatment (3 ,4). During renal failure, rhGH levels are often
normal but an increased number of binding proteins leaves fewer active rhGH available.
Terrill (4) reports that the administration of rhGH "usually improves growth in kids with
renal failure" as long as they have the capacity and potential for growth.
In contrast, some researchers have suggested that proper nutrition and adequate
caloric intake may prove to promote growth better than with the use of growth honnones.
According to Norman, et al, (5), this "optimal diet might be considered one that provides
sufficient energy and micronutrients to promote growth, while reducing excessive intakes
of protein, phosphate, and salt to limit progression of CRI and prevent the development
of renal osteodystrophy and anemia."
In an effort to further examine this theory, Norman, et al, (5) undertook an
observational study of the effects of medical and nutrition therapy on growth , the
progression of disease , and the overall nutrition status in children with CRI. This was a
particularly important study because the linear growth of a child with renal disease is the
physician's and dietitian's top priority.
The results of this study showed that the average caloric intake decreased over the
two year time period. The researchers also noted that an increase in caloric intakes
amongst children with severe CRI may be beneficial to growth rates and that the
administration of rhGH may not be needed. The researchers also state that the results of
this study point to placing emphasis on steadily increasing energy intakes rather than
focusing on the total amount of energy consumed.
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Although these results are promising, they are not concrete. The implications for
using growth honnones versus a proper diet is still vague, but Nonnan, et al, (5)
recommend that "rhGH is administered once assurance has been made that provision of
energy, protein , and micronutrients is adequate and that acidosis, hyperphosphatemia, and
secondary hyperparathyroidism have been corrected for." Also, these guidelines
recommend that rhGH should only be given once the child has reached at least -2
standard deviations for height-for-age (5).
Renal osteodystrophy , another important initiator of growth retardation, can be
appropriately controlled with nutrition therapy (3) . Calcium intake should be kept high
while phosphorus intake kept low. This ratio between calcium and phosphorus in
conjunction with active vitamin D therapy can help maintain the proper balance needed
to promote healthy bones and adequate growth (3).
Metabolic acidosis , which is common in renal failure, may also hinder growth by
creating a disturbance in the acid-base balance of the body (3,4). This decrease in blood
pH causes the bone to titrate acid, which in tum causes calcium to be drawn out from the
bones. This increased loss of calcium results in demineralization of the bones and adds to
the already present growth failure. Metabolic acidosis is relatively simple to correct by
administering sodium bicarbonate or sodium citrate and also through dialysis .
Another possible cause of growth failure in children is the restriction of protein
(3,4). This type of preventative treatment is very controversial. Some researchers
believe that restricting the intake of protein will help preserve function by lessening the
workload on the kidneys, while other researchers say that restricting protein among
children with renal disease prevents adequate growth . In addition, Terrill (4) reports that
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there is an "increased morbidity and mortality associated with inadequate calorie and
protein intake".

Appropriate protein intakes for these children are set at the minimum

recommended daily allowance (RDA) for their age group (3) and are as follows:
Age

Protein recommendations (for both males
and females) in grams /kilogram/day (6,7)

1-3 Years

1.1 g/kg

4-8 Years

0.95 g/kg

9-13 Years

0.95 g/kg

14-18 Years

0.85 g/kg

However, once the pediatric patient begins to receive dialysis treatment, the
recommendations for protein change. Protein requirements are typically increased with
the initiation of therapy because dialysis can drain the body of protein, and, thus, more
protein is needed to compensate . These increased protein recommendations are based on
type of therapy and the child's weight (3 ).
Hemodialysis Therapy

Continuous Ambulatory

(HD)

Peritoneal Dialysis (CAPD)
Therapy

10-20 kg

2.0 g/kg/day

2.0 g/kg/day

20-40 kg

1.0-1.5 g/kg/day

1.5 g/kg/day

40+ kg

1.0 g/kg/day

1.0-1.5 g/kg/day
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As noted before, protein intake is especially important because of the potentially
increased risk for morbidity, mortality, and growth failure. It has been proposed that low
serum albumin levels may also indicate higher risks for morbidity and mortality amongst
dialysis patients, especially the pediatric population (3,8).
Albumin is a serum protein that is largely regarded as a marker of nutritional
status (3,8). Thus, when serum albumin is low, malnutrition can often accompany it. In
a study by Brem, et al, (8), they hypothesize that a low serum albumin(< 2.9 mg/dl) in
children on maintenance peritoneal dialysis (PD) therapy is more prevalent than their
adult counterparts, thus putting them at greater risk for morbidity and mortality.
PD is usually the treatment of choice for children with ESRD (3,8). This is
mainly because a more normal lifestyle can be maintained with PD rather than with HD.
Automatic cyclic PD is a highly effective and efficient therapy, and thereby leads to an
increased drain and demand on protein stores. Also, researchers note that pediatric
patients on PD have lower serum albumin levels because of the obligatory losses in the
peritoneal cavity.
The results from the Brem, et al, (8) survey-study showed that over one-third of
pediatric PD patients had albumin levels less than 2 .9 mg/di , while none of the pediatric
HD patients showed albumin levels that low . This was disturbing to researchers because
an albumin of 2.9 mg/dl is extremely low, where the normal pediatric serum albumin cutoff point is 3.5 mg/di (8). This shockingly high number of pediatric PD patients with
very low serum albumin levels puts them at an increased risk for growth failure and comorbid conditions, such as infections, compared to their pediatric HD counterparts (8).
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Protein-energy malnutrition (PEM) and overall under-nutrition are serious
problems among pediatric renal patients and have been linked as other major causes of
growth restriction and retardation in this population (9). In addition to promoting good
oral intakes and adequate nutrition at home, intradialytic parenteral nutrition (IDPN) is an
alternate option in achieving optimal nutrition status.
IDPN is a form of supplemental parenteral nutrition that is usually administered
peripherally (3) . IDPN is not intended to meet all the nutrient requirements for an entire
day , but rather is a supplemental form of calories and protein given during the dialysis
treatment. IDPN has been proven to be very effective in adult dialysis patients but little
is known about the effects ofIDPN and pediatric patients (9).
Goldstein, et al, (9) set out to research the effects of IDPN supplementation
among severely malnourished adolescents on hemodialysis . The IDPN was indicated
because the adolescents had extensive gastrointestinal conditions (such as pancreatitis ,
gastritis, etc) that made it difficult for them to receive supplemental nutrition enterally.
After the administration of the IDPN solution for 18 months, the results showed that
these adolescents with PEM had gained weight, had an increase in their BMI, and now
weighed 90-100% of their ideal body weight. Although more research on the safety and
efficacy of IDPN for children are needed , the researchers concluded that IDPN is an
effective supplement for pediatric HD patients, especially those who are unable to
tolerate enteral fonnulas (9).
Many of the current research articles have focused on the increased risk for
morbidity and mortality among pediatric patients with ESRD. It becomes necessary to
clarify the difference in types and rates of morbidity and mortality in children compared
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to adults. Although preventing these problems is a primary goal in medical nutrition
therapy, the rates of mortality are much lower in children (4%) than in adults (23%) (10).
Also, serious co-morbid conditions, such as cardiovascular diseases (CVD) and anemia,
which are major concerns in the adult renal population, are not as significant in the
pediatric population. Children have much lower rates of CVD and seem to tolerate
anemia better than adults (10). Children also do not exhibit as many signs and symptoms
of the inability to function in their daily activities like many adults with ESRD do (10).
As explained before, anemia is another untimely side effect of failing kidneys (3).
The kidney manufactures erythropoietin (EPO) which is responsible for the production of
red blood cells in bone marrow. When EPO production is decreased or halted all
together, the amount of red blood cells is drastically reduced, resulting in hypochromic
anemia . Other causes of anemia are blood loss from HD and an iron-deficient diet (11).
This type of chronic anemia cannot be treated completely with nutrition. The most
common form of treatment is the administration of EPO in conjunction with iron
supplementation (3) . The additional iron is needed because the EPO stimulates rapid
production of red blood cells, which, in tum, causes an increased need for iron as well
( 11).
In addition to red blood cell count , hemoglobin and hematocrit levels are also
assessed to determine anemia status (12) . Schroder (12) lists the normal hemoglobin and
hematocrit values used as guidelines for diagnosing anemia. They are as follows:

Age

Hemoglobin (g/dl)

Hematocrit (%)

1-3 days

14.5-22.5

45-70

2 months

9.0-14.0

28-42

6-12 years

11.5-15 .5

35-45

12-18 years

Males : 13.0-16.0

Males: 37-49

Females: 12.0-16.0

Females: 36-46

The primary goal of nutrition therapy for pediatric patients is to attain proper
growth and promote adequate nutrition (3). Several barriers often get in the way of
meeting the recommended nutrition guidelines. These include anorexia, alterations in
taste, fatigue, a feeling of fullness , financial difficulties, dietary restrictions, and
excessive nutrient losses with dialysis (3,4). However, these barriers can be combated,
resulting in a more adequate nutritional status. By using the appropriate measures to
correct anemia , anorexia, fatigue , and taste alterations can be avoided. Also , imbalances
in electrolytes and other compounds in the body can also lead to skewed taste (3) .
Dialysis is the most common and effective method in treating renal failure and
restoring electrolyte and fluid homeostasis in the body . Although dialysis is needed for
correction and maintenance, side effects often accompany it. The biggest nutritional
barriers during peritoneal dialysis, are a premature feeling of fullness and excessive
losses of nutrients in the dialysate (3) .
Another reason for malnutrition is non-compliance to the prescribed dietary
restrictions (3,4). One of the more simple solutions, or preventions , is to individualize
the patient's diet and allow a feeling of autonomy. This helps the pediatric patient to feel
like they have some control in their lives and to not feel so constricted. However,
sometimes the problem can stem deeper than non-compliance .
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According to Snethen, et al (13), "the effects of chronic conditions in children and
adolescents can have an overwhelming impact on their development, not only physically,
but psycosocially as well." Denial and unacceptance of kidney disease and the
progression ofrenal failure is common among pediatric patients (3). ln addition, the
social and physical stresses of living with a chronic disease combined with the nonnal
stresses and hormones of adolescence can lead to such behavior as anger, moodiness, and
"acting out" (13 ).
Although music , friends, and confiding in a trusted professional are common
coping mechanisms used by patients (13 ), the dietitian can also help to relieve the angst
and pressure felt in ESRD. Simple ways to facilitate dietary compliance and promote
healthy coping mechanisms include a sense of sympathy, a highly individualized diet,
simplified instructions, multiple short counseling sessions, developing a good rapport
with the patient and family, and explaining the rationale behind the diet (4).
CONCLUSIONS:
In summary, the treatment of renal failure in children requires much dietary
intervention . Dietitians and nutrition professionals' roles are to calculate the needed
amounts of nutrients for growth and well-being , provide dietary counseling and guidance ,
and utilize skills and knowledge to maximize the quality of life in these pediatric patients.
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